Inventor · disambiguated record
Arthur Gomtsyan
Also filed as: GOMTSYAN ARTHUR · GOMTSYAN ARTHUR R
38 granted patents·10 pending applications·181 citations·filing 2001–2017
97Inventor score
Top patents by PatentIndex Score
48 records- 0195US7015233B2Fused compounds that inhibit vanilloid subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Mar 21, 2006·39 cites·15 claims
- 0293US8026256B2Fused compounds that inhibit vanilloid subtype 1 (VR1) receptorABBOTT LAB·Filed 2005·Granted Sep 27, 2011·11 cites·6 claims
- 0388US8487116B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2011·Granted Jul 16, 2013·5 cites·14 claims
- 0488US8084616B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 27, 2011·12 cites·13 claims
- 0587US8071762B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 6, 2011·5 cites·5 claims
- 0685US7998993B2TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·8 cites·15 claims
- 0785US7902236B2Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereofABBOTT LAB·Filed 2009·Granted Mar 8, 2011·7 cites·6 claims
- 0885US7504520B2Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereofABBOTT LAB·Filed 2006·Granted Mar 17, 2009·7 cites·51 claims
- 0985US6933311B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Aug 23, 2005·24 cites·23 claims
- 1083US7622493B2Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereofABBOTT LAB·Filed 2007·Granted Nov 24, 2009·6 cites·36 claims
- 1182US7074805B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Jul 11, 2006·10 cites·69 claims
- 1281US7998982B2Amide derivatives as TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·4 cites·6 claims
- 1381US7875627B2Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereofABBOTT LAB·Filed 2005·Granted Jan 25, 2011·4 cites·19 claims
- 1480US7335678B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptorABBOTT LAB·Filed 2004·Granted Feb 26, 2008·8 cites·12 claims
- 1578US7375126B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2004·Granted May 20, 2008·9 cites·8 claims
- 1676US8232309B2Prodrugs of compounds that inhibit TRPV1 receptorGOMTSYAN ARTHUR R·Filed 2006·Granted Jul 31, 2012·2 cites·22 claims
- 1776US6831193B2Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·8 cites·68 claims
- 1873US8604053B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 10, 2013·2 cites·32 claims
- 1970US8598220B2Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereofBROWN BRIAN S·Filed 2009·Granted Dec 3, 2013·1 cites·5 claims
- 2069US8772499B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·45 claims
- 2169US8772500B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·33 claims
- 2269US6693136B1Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Feb 17, 2004·7 cites·25 claims
- 2365US2008153809A1Novel amides useful for treating painABBOTT LAB·Filed 2008·Application pending·0 cites
- 2464US8247413B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorLEE CHIH-HUNG·Filed 2008·Granted Aug 21, 2012·0 cites·10 claims
- 2561US8030504B2Antagonists of the TRPV1 receptor and uses thereofABBOTT LAB·Filed 2007·Granted Oct 4, 2011·0 cites·9 claims
- 2655US2013165479A1Antagonists of the trpv1 receptor and uses thereofABBVIE INC·Filed 2012·Application pending·0 cites
- 2754US10266532B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 23, 2019·0 cites·18 claims
- 2853US8350083B2Antagonists of the TRPV1 receptor and uses thereofABBVIE INC·Filed 2011·Granted Jan 8, 2013·0 cites·16 claims
- 2952US8796328B2TRPV1 antagonistsABBVIE INC·Filed 2013·Granted Aug 5, 2014·0 cites·25 claims
- 3052US7812019B2Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofABBOTT LAB·Filed 2005·Granted Oct 12, 2010·0 cites·21 claims
- 3151US8609692B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 17, 2013·0 cites·24 claims
- 3250US2011144057A1Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereofABBOTT LAB·Filed 2011·Application pending·0 cites
- 3348US8338603B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2011·Granted Dec 25, 2012·0 cites·6 claims
- 3448US2003158188A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2002·Application pending·0 cites
- 3548US2012277190A1Prodrugs of compounds that inhibit trpv1 receptorGOMTSYAN ARTHUR R·Filed 2012·Application pending·0 cites
- 3646US8859584B2TRPV1 antagonistsABBVIE INC·Filed 2012·Granted Oct 14, 2014·0 cites·20 claims
- 3746US2011288129A1Amide derivatives as trpv1 antagonistsVASUDEVAN ANIL·Filed 2011·Application pending·0 cites
- 3844US2005113576A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2004·Application pending·0 cites
- 3942US9156788B2TRPV3 modulatorsABBVIE INC·Filed 2013·Granted Oct 13, 2015·0 cites·11 claims
- 4042US8969325B2TRPV1 antagonistsABBVIE INC·Filed 2012·Granted Mar 3, 2015·0 cites·31 claims
- 4140US8440691B2Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofGOMTSYAN ARTHUR·Filed 2010·Granted May 14, 2013·0 cites·18 claims
- 4239US9447051B2Diaminopyrimidines and uses thereofABBVIE INC·Filed 2013·Granted Sep 20, 2016·0 cites·8 claims
- 4339US8501769B2Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereofTURNER SEAN T·Filed 2010·Granted Aug 6, 2013·0 cites·5 claims
- 4438US2010210682A1Repeated Dosing of TRPV1 AntagonistsABBOTT LAB·Filed 2010·Application pending·0 cites
- 4537US2018243298A1Trpv3 modulatorsABBVIE INC·Filed 2016·Application pending·0 cites
- 4637US2002173665A1Trisubstituted-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit P2X3 and P2X2/3 containing receptorsFiled 2001·Application pending·0 cites
- 4732US9012651B2TRPV3 modulatorsCLAPHAM BRUCE·Filed 2012·Granted Apr 21, 2015·0 cites·9 claims
- 4831US8802711B2TRPV1 antagonistsGOMTSYAN ARTHUR·Filed 2012·Granted Aug 12, 2014·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Arthur Gomtsyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →